Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 8,497 | 16,072↑89.1% | 12,173↓24.3% | 13,117↑7.8% | 14,202↑8.3% |
| Gross Profit | 7,141 | 13,348↑86.9% | 10,468↓21.6% | 10,873↑3.9% | 12,232↑12.5% |
| Operating Income | 3,577 | 8,947↑150.1% | 5,386↓39.8% | 4,349↓19.3% | 3,991↓8.2% |
| Net Income | 3,513 | 8,075↑129.9% | 4,338↓46.3% | 3,954↓8.9% | 4,413↑11.6% |
| EBITDA | 4,103 | 9,669↑135.7% | 5,260↓45.6% | 4,693↓10.8% | 5,318↑13.3% |
| EPS Diluted | 30.52 | 71.97↑135.8% | 38.22↓46.9% | 34.77↓9.0% | 38.34↑10.3% |